| | |

New Lung Cancer Screening Guidelines Could Catch Some Mesotheliomas Earlier

new lung cancer screening guidelinesNew lung cancer screening guidelines for smokers might have an unexpected benefit for people who have also been exposed to asbestos: They may catch mesothelioma earlier. 

Malignant pleural mesothelioma is a lung-related cancer caused by asbestos. It develops over many years. Many mesothelioma patients do not show any symptoms until the disease is very advanced. There is currently no routine screening for mesothelioma.

The new lung cancer screening guidelines apply to people ages 50 to 80. They suggest that those who have smoked the equivalent of a pack a day for 20 years should have annual low-dose CT scans. 

If screening shows a tumor, doctors can dig further to determine its type. Both lung cancer and pleural mesothelioma are more responsive to treatment before they have spread. 

Understanding the New Lung Cancer Screening Guidelines

Lung cancer is the most common type of cancer in the US. Smoking is the biggest risk factor for lung cancer. In 2019, the National Lung Screening Trial concluded that low-dose CT scans of high risk patients reduced the risk of lung cancer by 20 percent. 

The new lung cancer screening guidelines come from the US Preventive Services Task Force. They apply to smokers between 50 and 80. 

The guidelines recommend a yearly low-dose CT scan for heavy smokers. A heavy smoker is anyone who has smoked the equivalent of a pack a day for 20 years. This could include people who smoked two packs a day for 10 years, or those who smoked less, but did so over a longer period of time. It also includes people who have quit within the past 15 years.

Malignant mesothelioma is most common in people who lived or worked around asbestos. Asbestos is the primary risk factor for mesothelioma. But studies show that asbestos workers who also smoke have an even higher risk for mesothelioma. 

By screening older smokers, the new lung cancer screening guidelines could help doctors identify and treat mesothelioma tumors they might otherwise miss. 

Low-Dose CT Scans and Mesothelioma

Malignant pleural mesothelioma is the most deadly disease caused by asbestos. Mesothelioma tumors grow on the lining around the lungs. Over time, they restrict the lungs’ ability to expand. The disease is usually fatal within a year. 

Germany has been covering low-dose CT screening for asbestos workers at risk of mesothelioma since 2016. A pair of radiology researchers summed up the decision in an article in the journal Radiologe

But not everyone agrees with the new lung cancer screening guidelines. Critics say LDCT for mesothelioma and lung cancer can lead to unnecessary radiation exposure, false positive results, overtreatment, and unneeded surgeries. 

An estimated 2,500 Americans receive a mesothelioma diagnosis each year. Most have Stage III or IV cancer by the time they are diagnosed. 

Source:

Lung Cancer: Screening, Final Recommendation Statement, March 9, 2021, US PReventive Services Task Force, https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • |

    Mesothelioma Case Shows Danger of Accidental Asbestos Exposure

    A mesothelioma case in Birmingham, England is a dramatic illustration of the very real danger of hidden asbestos. The widow of a physician who died of mesothelioma last year at the age of 51 claims her husband was exposed to asbestos just walking to and from his medical classes. Monisha Coelho believes that exposed asbestos insulation in the underground hallways that connect the University of Birmingham to buildings on the Queen Elizabeth Hospital campus triggered Dr. Ian Pardoe’s mesothelioma. In an article in the Birmingham Mail, Coelho explained how her husband decided how and where the deadly exposure had occurred. “Ian thought long and hard about where he might have come into contact with asbestos,” Coelho told the paper. “He…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    Short-term Asbestos Exposure Triggers Mesothelioma

    The recent death of a British man from mesothelioma is evidence of the destructive power of asbestos – even when exposure is short.  A British newspaper reports that Welwyn resident Roger Beale first began experiencing a classic symptom of mesothelioma, shortness of breath, nearly 4 years ago. Beale first noticed the problem while walking up stairs. After a chest X-ray, Beale’s symptoms were attributed to a chest infection.  But when his symptoms continued to worsen, Beale sought medical care again in January, 2010 and was diagnosed with pleural mesothelioma, an intractable cancer of the lung lining that is almost always caused by exposure to asbestos. By November of 2010, Beale’s shortness of breath had gotten worse, despite regular monitoring and…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…